Point Loma Resources Ltd (TSE:PLX) insider Madalena Energy Inc. sold 54,000 shares of the company’s stock in a transaction dated Thursday, January 12th. The stock was sold at an average price of C$0.42, for a total …
Point Loma Resources
Pluristem Therapeutics Inc. (NASDAQ:PSTI) announced that Germany’s health regulatory agency, the Paul Ehrlich Institute (PEI), has cleared Pluristem to begin enrollment in Germany for its pivotal Phase III trial of …
analysts
On the other hand, the company is also an attractive dividend growth stock as well. The combination of high growth ... strategy by merging with several chipmakers, including LSI, PLX Technology, Emulex, and, most …
Broadcom Limited
Protalix Biotherapeutics has a 1-year low of $0.41 and a 1-year high of $1.11. It indicates oversold and overbought price levels for a stock. Protalix Biotherapeutics (NYSE:PLX) opened at 0.482 on Thursday. The company has …
brokerage firms
The stock is trading below its 50-day moving average by 8.43%. Shares of the Company, which focuses on the …
shares
PLX) (TASE: PLX) today announced a review of the Company’s clinical and financial highlights for 2016, as well as an outlook for anticipated future strategic milestones. “2016 was a building year for Protalix. We …
Clinical Trial
PLx stockholders will receive newly issued shares of common stock of Dipexium in connection with the merger contemplated by the merger agreement. Dipexium will issue approximately 36 million new shares of its …
NASDAQ